EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cardiometabolic risk and vascular changes in rheumatic diseases

Yuliya Fedorchenko, Umida Khojakulova, Bekzhan A Permenov, Mykhailo Fedorchenko, Ahmet Usen

Rheumatology International · 19.05.2026 · 46 (6)

DOI: 10.1007/s00296-026-06129-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Rheumatology International, online erschienen am 19.05.2026. Verfasst von Yuliya Fedorchenko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine. Hauptthemen laut MEDLINE: Rheumatic Diseases, Atherosclerosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul Medipol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatic diseases (RDs) are chronic immune-mediated disorders associated with disproportionately increased cardiovascular morbidity and mortality. Accelerated atherogenesis in these diseases is driven by persistent systemic inflammation, autoantibody-mediated endothelial injury, oxidative stress, and dysregulated lipid metabolism, resulting in premature vascular remodeling manifested by increased carotid intima–media thickness, arterial stiffness, impaired flow-mediated dilation, and coronary artery calcification. This review synthesizes evidence regarding subclinical atherosclerosis and cardiometabolic risk across common RDs. In rheumatoid arthritis and systemic lupus erythematosus, vascular alterations correlate with inflammatory burden, disease duration, autoantibody profiles, renal involvement, and glucocorticoid exposure. Emerging biomarkers—including apolipoprotein B48, FIB-4 index, asymmetric dimethylarginine, and adhesion molecules—provide incremental prognostic value beyond traditional lipid parameters. Advanced imaging modalities, such as ^18F-sodium fluoride PET/CT and vascular elastography, enhance early detection of arterial calcification and stiffness. Growing evidence in primary Sjögren syndrome, Behçet disease, systemic sclerosis, and ankylosing spondylitis similarly confirms increased subclinical atherosclerosis and endothelial dysfunction. Importantly, tight disease control and targeted immunomodulatory therapies—including methotrexate, biologic agents, antimalarials, and cytokine-directed treatments—are associated with improved vascular and metabolic profiles and attenuation of disease progression. Subclinical atherosclerosis represents a critical interface between autoimmunity and cardiovascular disease in RDs. Early vascular assessment integrated with disease-specific and metabolic risk stratification is essential to implement precision-based cardiovascular prevention in this high-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rheumatic DiseasesAtherosclerosisHumansCardiometabolic Risk FactorsBiomarkersRisk Factors

Stichwörter der Autor:innen

AtherosclerosisCardiovascular diseasesEndothelial dysfunctionInflammationRheumatic diseases

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Pathophysiology, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine.
  • Department of Emergency Medicine and Nursing, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.
  • Department of Social Health Insurance and Public Health, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.
  • Department of Cardiac Surgery Anesthesiology and Intensive Care, Heart Center Shymkent, Shymkent, Kazakhstan.
  • Department of Internal Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkistan, Kazakhstan.
  • Department of Therapy, Family and Emergency Medicine of the Faculty of Medicine, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine.

Förderung

  • Istanbul Medipol University

Zitieren

APA

Fedorchenko, Y., Khojakulova, U., Permenov, B. A., Fedorchenko, M., & Usen, A. (2026). Cardiometabolic risk and vascular changes in rheumatic diseases. Rheumatology International, 46(6). https://doi.org/10.1007/s00296-026-06129-w

Vancouver

Fedorchenko Y, Khojakulova U, Permenov BA, Fedorchenko M, Usen A. Cardiometabolic risk and vascular changes in rheumatic diseases. Rheumatology International. 2026;46(6). doi:10.1007/s00296-026-06129-w

BibTeX
@article{Fedorchenko2026,
  author = {Fedorchenko, Yuliya and Khojakulova, Umida and Permenov, Bekzhan A and Fedorchenko, Mykhailo and Usen, Ahmet},
  title = {Cardiometabolic risk and vascular changes in rheumatic diseases},
  journal = {Rheumatology International},
  year = {2026},
  volume = {46},
  number = {6},
  doi = {10.1007/s00296-026-06129-w}
}
Kostenlos starten →